Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Energy Recovery, Inc.ERII · Entity 5679 | Director | June 15, 2026 | June 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Energy Recovery, Inc.
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 55,671 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Purchase · Acquired 11,180 · Balance 55,671 F1: This amount represents the weighted average purchase price of multiple trades ranging from $8.535 to $8.93 per share. The reporting person undertakes to provide the SEC Staff, Energy Recovery, Inc. or a shareholder of Energy Recovery, Inc. full information about the number of shares purchased at each separate price upon request. |
| Common StockSEC Table I · non-derivative | IndirectColin Sabol & Julie Sabol JTWROS | 3,000 |
Reported balance
Holding disclosure · report date 2026-06-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,000 |
Filing footnotes · ownership attribution and instrument terms
F1: This amount represents the weighted average purchase price of multiple trades ranging from $8.535 to $8.93 per share. The reporting person undertakes to provide the SEC Staff, Energy Recovery, Inc. or a shareholder of Energy Recovery, Inc. full information about the number of shares purchased at each separate price upon request.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Xylem Inc.
Report date May 06, 2022 · Filed May 06, 2022
Section 16 reporting ended · disclosed 2022-05-06. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 1,796 | $104.15 | $187,062.02 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · nonDerivative · entry 5 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,256 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,446 shares that were executed at prices ranging from $103.39 to $104.382 per Share. 350 shares were executed at prices ranging from $104.39 to $105.09. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 1,900 | $105.00 | $199,500.00 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · nonDerivative · entry 4 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,052 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. F3 · price: Shares were sold at an average execution price of $105.00. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 1,900 | $37.47 | $71,193.00 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · nonDerivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 1,900 | $104.15 | $197,893.74 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,052 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,654 shares that were executed at prices ranging from $103.60 to $104.52 per Share. 246 shares were executed at prices ranging from $104.72 to $105.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 1,900 | $37.47 | $71,193.00 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:40 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,196 | $0.00 Strike: $37.47 | $0.00 |
DisclosureSEC source: 0001209191-20-063815 · doc4.xml · derivative · entry 4 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,197 Underlying: Common · 5,196 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:40 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,067 | $98.31 | $203,201.40 |
DisclosureSEC source: 0001209191-20-063815 · doc4.xml · nonDerivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,052 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 67 shares that were executed at prices ranging from $98.13 to $99.12 per Share. 2,000 shares were executed at prices ranging from $99.13 to $99.36. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:40 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 5,196 | $98.31 | $510,805.25 |
DisclosureSEC source: 0001209191-20-063815 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,119 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,863 shares that were executed at prices ranging from $97.09 to $97.71 per Share. 2,333 shares were executed at prices ranging from $98.13 to $99.12. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:40 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 5,196 | $37.47 | $194,694.12 |
DisclosureSEC source: 0001209191-20-063815 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 20:06 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,197 | $0.00 Strike: $37.47 | $0.00 |
DisclosureSEC source: 0001209191-20-050451 · doc4.xml · derivative · entry 4 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,393 Underlying: Common · 5,197 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 20:06 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,066 | $84.36 | $174,282.18 |
DisclosureSEC source: 0001209191-20-050451 · doc4.xml · nonDerivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,119 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,435 shares that were executed at prices ranging from $83.53 to $84.48 per Share. 2,828 shares were executed at prices ranging from $84.54 to $85.13. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 20:06 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 5,197 | $84.36 | $438,404.89 |
DisclosureSEC source: 0001209191-20-050451 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,185 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,435 shares that were executed at prices ranging from $83.53 to $84.48 per Share. 2,828 shares were executed at prices ranging from $84.54 to $85.13. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 20:06 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 5,197 | $37.47 | $194,731.59 |
DisclosureSEC source: 0001209191-20-050451 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:10 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,197 | $0.00 Strike: $37.47 | $0.00 |
DisclosureSEC source: 0001209191-20-046343 · doc4.xml · derivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,590 Underlying: Common · 5,197 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:10 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 5,197 | $78.00 | $405,366.00 |
DisclosureSEC source: 0001209191-20-046343 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,185 F2 · price: This price represents the weighted average price per Share of the Issuer. 5,197 shares were sold at a price of $78.00 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:10 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 5,197 | $37.47 | $194,731.59 |
DisclosureSEC source: 0001209191-20-046343 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. Read SEC document |
| July 15, 2020 Filed Jul 16, 2020 14:59 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,066 | $75.00 | $154,950.00 |
DisclosureSEC source: 0001209191-20-042554 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,185 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. F2 · price: This price represents the weighted average price per Share of the Issuer. 2,066 shares were sold at a price of $75.00 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 18:41 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,066 | $75.05 | $155,053.30 |
DisclosureSEC source: 0001209191-20-018411 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,251 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. F2 · price: This price represents the weighted average price per Share of the Issuer. 2,066 shares were sold at prices ranging from $75.00 to $75.17 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:04 UTC | Xylem Inc. XYL · Entity 430 | GrantEmployee Stock Options (Right to Buy) · Derivative | 18,715 | $0.00 Strike: $80.66 | $0.00 |
DisclosureSEC source: 0001209191-20-014569 · doc4.xml · derivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,715 Underlying: Common Stock · 18,715 shares Expires 2030-02-27 F2 · derivative.exercise_date: These options vest in three equal annual installments beginning on February 27, 2021. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:04 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 3,719 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014569 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,317 F1 · shares: Reflects an award of restricted stock units which are scheduled to vest in three equal annual installments beginning on February 27, 2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:40 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 1,602 | $88.52 | $141,809.04 |
DisclosureSEC source: 0001209191-20-012646 · doc4.xml · nonDerivative · entry 6 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,598 F4 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance stock units granted on February 21, 2017 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:40 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 5,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012646 · doc4.xml · nonDerivative · entry 5 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,200 F5 · shares: Reflects acquisition of 5,393 shares of common stock upon vesting of performance based restricted stock units granted on February 21, 2017 upon achievement of performance criteria related to Total Shareowner Return Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:40 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 1,394 | $88.52 | $123,396.88 |
DisclosureSEC source: 0001209191-20-012646 · doc4.xml · nonDerivative · entry 4 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,807 F4 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance stock units granted on February 21, 2017 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:40 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 3,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012646 · doc4.xml · nonDerivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,201 F3 · shares: Reflects acquisition of 3,880 shares of common stock upon vesting of performance based restricted stock units granted on February 21, 2017 upon achievement of performance criteria related to ROIC. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:40 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 330 | $88.52 | $29,211.60 |
DisclosureSEC source: 0001209191-20-012646 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,321 F2 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on February 21, 2018 under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:40 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 383 | $88.52 | $33,903.16 |
DisclosureSEC source: 0001209191-20-012646 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,651 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on February 21, 2017 under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 23:20 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 400 | $88.66 | $35,464.00 |
DisclosureSEC source: 0001209191-20-012180 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,034 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on February 20, 2019 under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 14:17 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 4,080 | $79.26 | $323,384.47 |
DisclosureSEC source: 0001209191-20-001490 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,434 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019. F2 · price: This price represents the weighted average price per Share of the Issuer. 3,801 shares were sold at prices ranging from $78.82 to $79.71 per Share. An additional 279 shares were sold at prices ranging from $79.85 to $79.90. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 19:19 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 3,004 | $77.74 | $233,530.96 |
DisclosureSEC source: 0001209191-19-051559 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,514 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019. F2 · price: This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $76.95 to $79.91 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 19:19 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 1,095 | $80.09 | $87,698.55 |
DisclosureSEC source: 0001209191-19-051559 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,518 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 17:44 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 1,168 | $84.33 | $98,494.29 |
DisclosureSEC source: 0001209191-19-040811 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,613 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019. F3 · price: This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $83.95 to $84.68 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 17:44 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,832 | $84.27 | $238,643.29 |
DisclosureSEC source: 0001209191-19-040811 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,781 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $83.82 to $84.73 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 15:30 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,930 | $0.00 Strike: $35.96 | $0.00 |
DisclosureSEC source: 0001209191-19-024453 · doc4.xml · derivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,930 shares Expires 2025-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 15:30 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 15,930 | $80.45 | $1,281,549.38 |
DisclosureSEC source: 0001209191-19-024453 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,613 F2 · price: 4,879 shares were sold at an average execution price of $80.12. This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $79.39 to $80.38 per Share. An additional 11,051 shares were sold at an average execution price $80.5939. This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $80.39 to $80.94 per Share. The weighted average price of both trades is $80.4488. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 15:30 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionCommon Stock | 15,930 | $35.96 | $572,842.80 |
DisclosureSEC source: 0001209191-19-024453 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019. Read SEC document |
| February 24, 2019 Filed Feb 27, 2019 00:53 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 3,915 | $75.26 | $294,642.90 |
DisclosureSEC source: 0001209191-19-013849 · doc4.xml · nonDerivative · entry 5 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,613 F3 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance stock units granted on February 24, 2016 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 24, 2019 Filed Feb 27, 2019 00:53 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 8,757 | $75.26 | $659,051.82 |
DisclosureSEC source: 0001209191-19-013849 · doc4.xml · nonDerivative · entry 4 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,528 F4 · shares: Reflects acquisition of 8,757 shares of common stock upon vesting of performance based restricted stock units granted on February 24, 2016 upon achievement of performance criteria related to Total Shareowner Return Read SEC document |
| February 24, 2019 Filed Feb 27, 2019 00:53 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 3,575 | $75.26 | $269,054.50 |
DisclosureSEC source: 0001209191-19-013849 · doc4.xml · nonDerivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,771 F3 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance stock units granted on February 24, 2016 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 24, 2019 Filed Feb 27, 2019 00:53 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 8,757 | $75.26 | $659,051.82 |
DisclosureSEC source: 0001209191-19-013849 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,346 F2 · shares: Reflects acquisition of 8,757 shares of common stock upon vesting of performance based restricted stock units granted on February 24, 2016 upon achievement of performance criteria related to ROIC. Read SEC document |
| February 24, 2019 Filed Feb 27, 2019 00:53 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 746 | $75.26 | $56,143.96 |
DisclosureSEC source: 0001209191-19-013849 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,589 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on February 24, 2016 under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 22:51 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 326 | $74.32 | $24,228.32 |
DisclosureSEC source: 0001209191-19-013137 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,335 F2 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on February 21, 2018 under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 22:51 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 426 | $74.32 | $31,660.32 |
DisclosureSEC source: 0001209191-19-013137 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,661 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on February 21, 2017 under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 22:13 UTC | Xylem Inc. XYL · Entity 430 | GrantEmployee Stock Options (Right to Buy) · Derivative | 16,120 | $0.00 Strike: $74.07 | $0.00 |
DisclosureSEC source: 0001209191-19-012691 · doc4.xml · derivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,120 Underlying: Common Stock · 16,120 shares Expires 2029-02-20 F2 · derivative.exercise_date: These options vest in three equal annual installments beginning on February 20, 2020. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 22:13 UTC | Xylem Inc. XYL · Entity 430 | GrantCommon Stock | 3,713 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012691 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,087 F1 · shares: Reflects an award of restricted stock units which are scheduled to vest in three equal annual installments beginning on February 20, 2020. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 21:36 UTC | Xylem Inc. XYL · Entity 430 | Tax withholdingCommon Stock | 2,453 | $68.02 | $166,853.06 |
DisclosureSEC source: 0001209191-18-057418 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,374 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on November 2, 2015 under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 21:25 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $35.96 | $0.00 |
DisclosureSEC source: 0001209191-18-051667 · doc4.xml · derivative · entry 8 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,930 Underlying: Common Stock · 4,000 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 21:25 UTC | Xylem Inc. XYL · Entity 430 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,017 | $0.00 Strike: $38.76 | $0.00 |
DisclosureSEC source: 0001209191-18-051667 · doc4.xml · derivative · entry 7 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,017 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 21:25 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 2,500 | $81.37 | $203,425.00 |
DisclosureSEC source: 0001209191-18-051667 · doc4.xml · nonDerivative · entry 6 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,827 F4 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018 F6 · price: This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $80.91 to $81.64 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 21:25 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 3,644 | $81.37 | $296,512.28 |
DisclosureSEC source: 0001209191-18-051667 · doc4.xml · nonDerivative · entry 5 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,327 F4 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018 F5 · price: This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $80.84 to $81.60 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 21:25 UTC | Xylem Inc. XYL · Entity 430 | SaleCommon Stock | 4,000 | $81.37 | $325,480.00 |
DisclosureSEC source: 0001209191-18-051667 · doc4.xml · nonDerivative · entry 4 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,971 F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018. F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $80.87 to $81.64 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.